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Background: Carcinosarcomas are biphasic tumors consisting of 
an admixture of malignant epithelial and stromal elements without 
areas of transition between both elements, and each of these elements 
showing distinct inmuhistochemical features. This rare tumor is most 
commonly seen in the female genital tract. Pulmonary carcinosarcoma 
was ﬁrst described in 1951 and is the fourth common site; it consti-
tutes 0.2% of primary pulmonary malignancies. Metastases have been 
reported to adrenals, kidney, bone, brain and liver and occur especially 
from the sarcomatous component. We present a case of pulmonary 
carcinosarcoma with metastases from the sarcomatous component to 
the soft tissues of the face
Case Report: Female 64 years-old with a 1 year history of cough and 
hemoptysis, during assessment a chest x ray revealed a right pulmonary 
nodule and a subsequent chest CT showed a tumor depending on the 
medial segment from the middle lobe, no metastasic mediastinal nodes 
and no adrenal gland metastases were identiﬁed. A transthoracic ﬁne 
needle aspiration was performed and a diagnosis of adenocarcinoma 
was emitted by our cytologist. A PET scan showed only a lesion in 
the right lung and discarded nodal and metastasic disease. Then she 
was carried out to surgical resection and superior bi-lobectomy with 
mediastinal node mapping was performed. At pathological examina-
tion a carcinosarcoma of the lung was reported, tumor size 5.5x 3.7 
cm, no nodal involvement (pT2 pN0 M0 stage IB). One month later 
she developed a preauricular cutaneous nodule, a cytology reported a 
spindle-cell neoplasm and a subsequent excisional biopsy conﬁrmed a 
metastatic spindle-cell neoplasm from the sarcomatous component of 
the carcinosarcoma. Actually she is under palliative chemotherapy with 
doxrrubicin and cisplatin after three months form initial surgery.
Discussion: Carcinosarcoma of the lung remains an unusual tumor. 
It occurs most commonly in males with a 3:1 ratio, particularly in 
smokers, with a mean age of diagnosis of 63 years. Clinical symptoms 
depend on the size and localization of the tumor. The earliest and most 
frequent are usually due to bronchial obstruction. Peripheral lesions 
can be asymptomatic for a long time. The most accepted theory about 
the pathogenesis is that there is a malignant transformation of a single 
cell line, which can undergo clonal evolution and differentiation into 
a variety of carcinomatous and sarcomatous components. Inmunohis-
tochemical and ultraestructural studies support this theory. Preopera-
tive assessment and even intraoperative ﬁndings can not differentiate 
carcinosarcoma from other lung malignancies. Most cases are operable 
when ﬁrst discovered and treatment should be surgery, the prognosis is 
poor, with an average postoperative survival of nine months and only 
10% will survive two years. 
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Pulmonary metastases from a giant tumor cell of bone. A case 
report
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Background: Giant cell tumor of bone is a benign but locally aggres-
sive neoplasm that usually involves the end of long bones. This tumor 
is seen in young adults between 20 and 40 years of age and equally in 
both genders. The most frequent locations are distal femur, proximal 
tibia, distal radius and sacrum. Lung metastases have been previously 
reported in the course of this benign tumor. We present a case of a giant 
cell tumor of the distal femur with recurrence as multiple lung metasta-
ses 12 years after the treatment of the primary tumor.
Case Report: Female 41 years-old, known in our unit in 1985 for a 
giant cell tumor of distal femur, treated initially with curettage. On fol-
low up a local recurrence was detected four years later and treated with 
resection of distal femur and proximal tibia, on histology a giant cell 
tumor of bone was reported and free surgical margins were achieved. 
After surgery she was lost from follow up during eight years until she 
developed hemoptysis and dyspnea. An initial chest x ray ﬁlm revealed 
a left lung nodule suspicious of malignancy. On further assessment 
a chest CT scan documented a metastatic lesion on the left superior 
lobe with involve of the main stem bronchi with another small lesion 
in the periphery of the left inferior lobe. She was carried out to left 
thoracotomy with ﬁnding of multiple metastatic lesions less than 10 
mm in diameter so the disease was considered unresectable, and only 
a bleeding lesion was resected for palliation of hemoptysis. No further 
treatment was considered on postoperative. Three months later she de-
veloped chest pain and a new episode of hemoptysis and anemia and a 
chest CT scan showed progression of the disease so she was considered 
for palliative radiotherapy.
Discussion: Lung metastasis from a giant cell tumor of bone is a rare 
phenomenon, the incidence is said to be from 1% to 3%. On the histol-
ogy the metastases are identical to the primary tumor. Risk factors 
for the development of metastases are location on the distal radius or 
sacrum, stage 3 lesions and multiple recurrences. The proposed way 
of dissemination is the hematogenous and curettage of the primary 
tumor has also been implicated. The interval between initial surgery 
and pulmonary metastases is in average 2 years. Presentation tends to 
be as multiple nodules on bilateral ﬁelds and located in the periphery. 
Management includes surgery as the primary treatment, and it should 
be done as soon as possible, however in the cases with unresectable 
disease radiotherapy can be used but the results are variable and a 
risk of malignant transformation exists. Chemotherapy has been only 
reported in few cases and there is little information about its use. The 
behavior of metastasizing lesions is unpredictable since progression is 
usually slow and spontaneous regression has been reported. Actually 
is considered that lung metastases from a giant cell tumor of bone still 
having a favorable prognosis, with a 5 year survival from 80% to 85%.
